An international multicentre validation experiment for MOG antibodies

An international multicentre validation experiment for MOG antibodies

Bibliographic Details
Main Authors:	Reindl, M, Schanda, K, Woodhall, M, Tea, F, Ramanathan, S, Teegen, B, Sagen, J, Fryer, J, Mills, J, Mindorf, S, Ritter, N, Krummrei, U, Stoecker, W, Eggert, J, Rostasy, K, Berger, T, Irani, S, Dale, R, Probst, C, Brilot, F, Probst, M, Pittock, S, Waters, P
Format:	Conference item
Published:	SAGE Publications 2018

Similar Items

International multicenter examination of MOG antibody assays
by: Reindl, M, et al.
Published: (2020)

A multicenter comparison of MOG-IgG cell-based assays
by: Waters, P, et al.
Published: (2019)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
by: Spatola, Marianna, et al.
Published: (2023)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
by: Pace, S, et al.
Published: (2021)

Peripheral nervous system involvement in MOG antibody-associated demyelination
by: Ramanathan, S, et al.
Published: (2019)

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders
by: Rinaldi, S, et al.
Published: (2020)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
by: Waters, P, et al.
Published: (2015)

Recurrent optic neuritis associated with MOG antibody seropositivity
by: Chang, T, et al.
Published: (2017)

Origins and immunopathogenesis of autoimmune central nervous system disorders
by: Ramanathan, S, et al.
Published: (2023)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
by: Waters, P, et al.
Published: (2015)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
by: Elsone, L, et al.
Published: (2014)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
by: Hyun, J, et al.
Published: (2018)

MOG-IgG1 antibodies in children
by: Waters, P, et al.
Published: (2018)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2016)

We need to talk about MOG
by: Waters, P, et al.
Published: (2020)

Disease course and disability outcomes in MOG-antibody disease in the UK
by: Jurynczyk, M, et al.
Published: (2017)

GABAA receptor autoimmunity: a multicenter experience
by: O'Connor, K, et al.
Published: (2019)

MOG-IgA as a potential marker of germinal center activity
by: Handel, AE, et al.
Published: (2024)

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
by: Kaneko, K, et al.
Published: (2016)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
by: Jarius, S, et al.
Published: (2018)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
by: Jurynczyk, M, et al.
Published: (2017)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.
by: Morris, K, et al.
Published: (2015)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
by: Kwon, Y, et al.
Published: (2019)

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
by: Kim, Y, et al.
Published: (2020)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
by: Lang, B, et al.
Published: (2017)

Prospective clinical and MRI characterization of children with serum anti-MOG antibodies meeting the multiple sclerosis diagnostic criteria
by: Fadda, G, et al.
Published: (2018)

Applications of the gauge/gravity duality
by: Probst, J
Published: (2017)

No strong HLA association with MOG antibody disease in the UK population
by: Grant-Peters, M, et al.
Published: (2021)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
by: Luppe, S, et al.
Published: (2014)

Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres
by: Waters, P, et al.
Published: (2014)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
by: Juryńczyk, M, et al.
Published: (2016)

Metathesis in metal – organic gels (MOGs) : a facile strategy to construct robust fluorescent Ln‐MOG sensors for antibiotics and explosives
by: Qin, Zheng-Sheng, et al.
Published: (2020)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
by: Jurynczyk, M, et al.
Published: (2017)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, P, et al.
Published: (2016)

Becoming families: a study of same-sex couples' rights in the Anglo-Saxon countries
by: Probst, GPA
Published: (2020)

Bayesian analysis of stochastic point processes for financial applications
by: Probst, C
Published: (2013)

Anti-MOG Antibody Seropositive Patient Successfully Treated with Intermittent Rituximab Infusion
by: Kim, W, et al.
Published: (2014)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
by: Whittam, DH, et al.
Published: (2020)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
by: Sato, D, et al.
Published: (2014)